Anjan Selz

home / authors / anjan-selz

Anjan Selz is CEO and co-founder of Finox Biotech

Articles

The Drive for Best Practice in Biopharmaceutical Manufacturing

Anjan Selz

March 1st 2012

Key business considerations when developing biosimilar products virtually.

Anjan Selz

December 5th 2011

How does working in a virtual biotech environment affect biosimilar development? Anjan Selz outlines target and partner selection in this first of a two part article.

Anjan Selz

December 5th 2011

Virtual biotech CEO Anjan Selz focuses on product development, credibility and differentiation.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: December 9th 2024 | Updated: December 22nd 2024

Recap Key Industry Trends for Viral Clearance and NGS

Published: December 7th 2024 | Updated: December 22nd 2024

Enhancing Quality Through Training

Published: July 20th 2020 | Updated: December 22nd 2024

Contact BioPharm International Editors

Published: July 19th 2020 | Updated: December 22nd 2024

Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777